Alloy Therapeutics Partners With Institute for Protein Innovation to Advance Next-Generation Antibody Discovery

Alloy Therapeutics announced a strategic collaboration with the Institute for Protein Innovation (IPI) to develop next-generation antibody discovery technologies focused on highly engineered VHH (nanobody) libraries. The partnership combines Alloy’s scalable drug discovery infrastructure with IPI’s expertise in synthetic antibody discovery and protein engineering to support development of more advanced bispecific and multispecific therapeutics. Together, the organizations aim to make sophisticated antibody discovery tools more accessible across biotech and pharmaceutical research while accelerating development against difficult biological targets such as those in neuroscience and complex diseases. 

Learn More